Founded
1 Aug 2003
Address
De Novo Ventures
2180 Sand Hill Road
Suite 300
Menlo Park, CA 94025
United States
Phone
Website
VCID: 30720
Profile
Corporate information
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Apr 2011 1 Jun 2012 |
Series D |
|
|
|
EndoGastric Solutions Inc |
United States | 1 Jan 2010 1 Jun 2012 30 Jun 2009 |
Series F Initial investment. Round participant. Active |
|
|
|
Astute Medical Inc Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers |
United States | 1 Jun 2012 1 Mar 2011 |
Series C |
|
|
WaveTec Vision Systems Inc |
United States | 1 Apr 2012 1 May 2011 |
Venture Follow-on investment. Round participant. Active |
|
|
|
Myoscience Inc |
United States | 1 Mar 2012 | Series D |
|
|
|
Hemaquest Pharmaceuticals Inc |
United States | 1 Apr 2010 1 Mar 2012 |
Series B Active |
|
|
|
Avedro Inc A medical device company focused on vision correctional devices and has developed innovative ophthalmology solutions for the Lasik and myopia markets. |
United States | 1 Jul 2011 | Series C |
|
|
|
Spinal Modulation Inc Medical devices research and development company. |
United States | 9 Nov 2009 15 Jun 2011 |
Series D Active |
|
|
|
Spiracur Inc A medical device company focused on the development of innovative wound healing technologies. |
United States | 1 Feb 2011 | Venture |
|
|
|
TRIA Beauty Inc |
United States | 1 Sep 2010 | Venture |
|
|
|
TearScience Inc Developer of a diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. |
United States | 1 May 2010 | Series C Active |
|
|
|
Pulmonx Inc |
United States | 1 Mar 2010 | Series C Active |
|
|
|
Facet Solutions Developing surgical devices to treat spinal stenosis. |
United States | 1 Nov 2009 | Series C |